Roche asks court to stop launch of Novartis’ MabThera biosimilar

Intellectual Property 2018-05-15 10:45 pm By Miklos Bolza | Sydney

Drug giant F. Hoffman-La Roche asked the Federal Court Tuesday for an order barring the release of a generic version of its blockbuster cancer drug MabThera by a unit of Swiss rival Novartis, which it claims could lead to “tens of millions of dollars” in losses.